Form 4 for BBIO BridgeBio Pharma, Inc.
Accepted 2022-01-03 00:00:00 ET · period of report 2021-12-29 · accession 0000899243-22-000174 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-03 | 2021-12-29 | BBIO | MOMTAZEE JAMES C | Dir | P - Purchase | $14.50 | +80.0K | 88.5K | +942% | +$1.16M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-29 | P | A | 80,000 | $14.50 | 88,491 | D | — | — |